Callander, N., Markovina, S., Eickhoff, J., Hutson, P., Campbell, T., Hematti, P., . . . Miyamoto, S. (2014). Acetyl-l-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: A study from the Wisconsin Oncology Network. Springer Berlin Heidelberg.
Citação norma ChicagoCallander, Natalie, et al. Acetyl-l-carnitine (ALCAR) for the Prevention of Chemotherapy-induced Peripheral Neuropathy in Patients With Relapsed or Refractory Multiple Myeloma Treated With Bortezomib, Doxorubicin and Low-dose Dexamethasone: A Study From the Wisconsin Oncology Network. Springer Berlin Heidelberg, 2014.
MLA citiranjeCallander, Natalie, et al. Acetyl-l-carnitine (ALCAR) for the Prevention of Chemotherapy-induced Peripheral Neuropathy in Patients With Relapsed or Refractory Multiple Myeloma Treated With Bortezomib, Doxorubicin and Low-dose Dexamethasone: A Study From the Wisconsin Oncology Network. Springer Berlin Heidelberg, 2014.